Anika Therapeutics | ANIK - Frais De Vente Et D'Administration

Prix De L'Action
14.27
Variation Quotidienne
0.42 3.03%
Mensuellement
31.52%
Annuel
-7.88%
Q1 Prévisions
13.43




Frais De Vente Et D'Administration Changement Date
Abbott USD 3.13B 125M 2025-12
Agenus USD 10.56M 13.04M 2025-12
Agios Pharmaceuticals USD 42.97M 1.7M 2025-12
Anika Therapeutics USD 10.01M 14K 2025-12
Arrowhead Research USD 46.02M 8.84M 2025-12
Enanta Pharmaceuticals USD -1.05 0.31 2024-12
Halozyme Therapeutics USD 64.64M 27.11M 2025-12
Heron Therapeutics USD 23.74M 605K 2025-12
Insmed USD 212.48M 26.11M 2025-12
Integra LifeSciences USD 156.45M 12.6M 2025-12
Intrexon USD 10.31M 41K 2024-06
J&J USD 6.75B 831M 2025-12
Karyopharm Therapeutics USD 27.19M 442K 2024-12
Ligand Pharmaceuticals USD 28.45M 8.27M 2025-09
MacroGenics USD 7.94M 1.96M 2025-12
Merit Medical Systems USD 114.83M 7.45M 2025-12
Rigel Pharmaceuticals USD 27.04M 1M 2024-09
Sangamo BioSciences USD 9.64M 1.83M 2024-06
Sanofi EUR 2.75B 455M 2025-12
Smith & Nephew USD 1.42B 65M 2025-12
Stryker USD 2.14B 150M 2025-12
Surmodics USD 14.58M 2.05M 2024-09
Veracyte USD 43.31M 8.43M 2025-12
Xencor USD 17.04M 70.74M 2025-12
Zimmer Biomet Holdings USD 855.7M 44.3M 2025-12